Jump to main content
eTG Complete
Index
Search
Home
Rheumatology
Antiphospholipid syndrome
Management for people with persistent antiphospholipid (aPL) antibodies
Rheumatology
Assessment and initial management of musculoskeletal symptoms
Practical information on drugs used for musculoskeletal and rheumatological conditions
Adult-onset Still disease
Antiphospholipid syndrome
Overview of antiphospholipid syndrome
Diagnosis of antiphospholipid syndrome
Clinical manifestations of thrombotic antiphospholipid syndrome
Clinical manifestations of obstetric antiphospholipid syndrome
Other manifestations of antiphospholipid syndrome
Management overview for people with persistent antiphospholipid antibodies and people with antiphospholipid syndrome
Management for people with persistent antiphospholipid (aPL) antibodies
Primary thromboprophylaxis for asymptomatic people with persistent aPL antibodies who are thromboembolism-free
Primary thromboprophylaxis for asymptomatic people with persistent high-risk aPL-antibody profiles, who are thromboembolism-free and trying to conceive
Primary thromboprophylaxis for asymptomatic people with SLE and persistent aPL antibodies who are thromboembolism-free
Management for thrombotic antiphospholipid syndrome
Management for obstetric antiphospholipid syndrome
References
Autoinflammatory periodic fever syndromes
Back pain
Behçet syndrome
Crystal diseases including gout
Fibromyalgia
Idiopathic inflammatory myopathies
Immunoglobulin G
4
-related disease
Inflammatory connective tissue diseases
Juvenile idiopathic arthritis
Overview of limb conditions
Upper limb conditions
Lower limb conditions
Neck pain
Osteoarthritis
Musculoskeletal conditions in children and adolescents
Polymyalgia rheumatica
Pregnancy-related low back pain and pelvic pain
Raynaud phenomenon
Rheumatoid arthritis
Spondyloarthritis
Systemic vasculitides
Transition of adolescents to adult rheumatology management
Viral arthritis
Management for people with persistent antiphospholipid (aPL) antibodies
Primary thromboprophylaxis for asymptomatic people with persistent aPL antibodies who are thromboembolism-free
Primary thromboprophylaxis for asymptomatic people with persistent high-risk aPL-antibody profiles, who are thromboembolism-free and trying to conceive
Primary thromboprophylaxis for asymptomatic people with SLE and persistent aPL antibodies who are thromboembolism-free
